1.Clinical Observation on Treatment of Malignant Pleural Effusion Caused by Lung Cancer with Thoracoscopic Intrapleural Perfusion Hyperthermic Chemotherapy
Xing FENG ; Hu LI ; Guoqing WANG ; Xixian ZHANG ; Baogen MAO
Journal of Medical Research 2006;0(12):-
Objective To explore the methods of thoracoscopic intrapleural perfusion hyperthermic chemotherapy(TIPHC)on diagnosing and treating malignant pleural effusion caused by lung cancer,as well as its effect.Methods From February 1999 to March 2006,seventy patients with malignant pleural effusion caused by lung cancer were randomly divided into therapeutic group(35 cases)and control group(35 cases).Pleural biopsy and TIPHC under general anesthesia with unilateral ventilation were performed in the therapeutic group,and intrapleural injection of cisplatin was administered in the control group after drainage of pleural effusion.The effect on malignant pleural effusion,the change for the concentration of carcino-embryonic antigen(CEA),cytokeratin-19 fragments(CYFRA21-1),neuron-specific enolase(NSE)and the side effect were compared before and after the treatment.Results The therapeutic group achieved total response rate of 100%,but only 54.3% in the control group,with significant difference(P
2.Expression and significance of HBx protein in HBV-related hepatocellular carcinoma and its impacts on prognosis
Xianhui YU ; Yehong YAN ; Chunhua DONG ; Jianfeng LI ; Jiansheng XIAO ; Baogen LI ; Jianxiang WANG
Chinese Journal of General Surgery 2017;32(11):952-955
Objective To explore the relationship between the expression of HBx protein in HBV-related HCC samples and the clinical implications.Methods Elivision two-step was used in this study to detect the expression level of HBx protein in 40 HCC tissues,corresponding para-tumorous tissues from patients with HBV-related HCC undergoing curative hepatectomy.The relationship between HBx protein and clinical parameters (such as gender,age,TNM stage,HBV-DNA load,AFP,liver cirrhosis,a merger of vascular invasion,tumor infiltrating lymphocytes,Edmondson-Steiner histopathological grading,with or without relapse within 24 months) were analyzed.Results (1) The expression of HBx protein in the tumorous tissues was significantly lower than that of para-tumorous tissues (P < 0.05).(2) In the tissues of para-tumorous,the expression of HBx protein in group HBV-DNA < 500 IU/ml was significantly lower than that of group HBV-DNA≥500 IU/ml (P <0.05).There were no significant differences in the expression of HBx protein irrespective of gender,age,cirrhosis and the AFP level.(3) In the tissues of tumorous,the expression of HBx protein in group with vascular invasion was significantly higher than that of group without vascular invasion (P < 0.05).However,there were no significant differences in the expression of HBx protein among the factors of TNM stage and Edmondson-Steiner histopathology grading.(4) In para-tumorous tissues,the expression of HBx protein in group of lymphocytic infiltration was significantly higher than that without lymphocytic infiltration (P < 0.05).In the tissues of tumorous,the expression of HBx protein in disease-free survival (DFS) < 24M patients was significantly higher than DFS ≥ 24M (P < 0.05).Conclusions High HBx expression in tumor tissues indicates poor prognosis while that in para-tumorous tissues predicts a better prognosis.
3.Construction of a nomogram prediction model for the prognosis of gastric cancer patients based on the inflammatory response marker scoring system
LUO Junfeng ; HU Jun ; LI Baogen ; ZHOU Wenbin ; LYU Yuliang
Chinese Journal of Cancer Biotherapy 2023;30(10):902-907
[摘 要] 目的:根据胃癌患者术前中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)、淋巴细胞与单核细胞比值(LMR)的表达水平构建炎症反应评分(IRS)系统,分析IRS对胃癌患者术后预后的影响并构建列线图预测模型。方法: 选取2016年1月至2020年1月宜春市人民医院普外科收治的211例胃癌患者的临床资料,根据随访成功的198例患者术后3年生存状态分为死亡组(n=93)和生存组(n=105)。比较两组患者的一般临床资料,多因素COX回归风险模型分析影响胃癌患者预后的独立风险因素,R语言rms包构建列线图预测模型。结果: 两组胃癌患者肿瘤最大直径、病理分期、T分期、分化程度、神经侵犯、脉管侵犯、NLR、PLR、LMR比较差异均有统计学意义(均P<0.05)。依据NLP、PLR、LMR-IRS(NPL-IRS)构建标准,不同分值的胃癌患者OS率表现出一定的等级趋势差异(χ2=61.129,P<0.01)。病理分期Ⅲ期、分化程度低、脉管侵犯、NPL-IRS>1分是影响胃癌患者预后的独立危险因素(P<0.05)。决策曲线分析显示,风险阈值>0.16时,此预测模型可以提供显著额外的临床净收益。结论: 基于病理分期Ⅲ期、分化程度低、脉管侵犯、NPL-IRS>1分构建的列线图预测模型可以为胃癌患者预后评估提供重要的策略指导。